相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Monitoring chronic headache and medication-overuse headache prevalence in Denmark
Maria Lurenda Westergaard et al.
CEPHALALGIA (2020)
Major depression subtypes are differentially associated with migraine subtype, prevalence and severity
Claudia Pisanu et al.
CEPHALALGIA (2020)
The IUPHAR/BPS Guide to PHARMACOLOGY in 2020: extending immunopharmacology content and introducing the IUPHAR/MMV Guide to MALARIA PHARMACOLOGY
Jane F. Armstrong et al.
NUCLEIC ACIDS RESEARCH (2020)
Acid-sensing ion channel 3 blockade inhibits durovascular and nitric oxide-mediated trigeminal pain
Christopher M. Holton et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Long-Term Safety Evaluation of Ubrogepant for the Acute Treatment of Migraine: Phase 3, Randomized, 52-Week Extension Trial
Jessica Ailani et al.
HEADACHE (2020)
Lasmiditan inhibits calcitonin gene-related peptide release in the rodent trigeminovascular system
Alejandro Labastida-Ramirez et al.
PAIN (2020)
Safety, tolerability, and efficacy of orally administered atogepant for the prevention of episodic migraine in adults: a double-blind, randomised phase 2b/3 trial
Peter J. Goadsby et al.
LANCET NEUROLOGY (2020)
Soluble ligands as drug targets
Misty M. Attwood et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Current Status of Antiepileptic Drugs as Preventive Migraine Therapy
Simy K. Parikh et al.
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2019)
Effectiveness of intravenous dexamethasone, metoclopramide, ketorolac, and chlorpromazine for pain relief and prevention of recurrence in the migraine headache: a prospective double-blind randomized clinical trial
Mojtaba Khazaei et al.
NEUROLOGICAL SCIENCES (2019)
Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine
Peter J. Goadsby et al.
BRAIN (2019)
Effects of monoclonal antagonist antibodies on calcitonin gene-related peptide receptor function and trafficking
Raffi Manoukian et al.
JOURNAL OF HEADACHE AND PAIN (2019)
Spreading depression as a preclinical model of migraine
Andrea M. Harriott et al.
JOURNAL OF HEADACHE AND PAIN (2019)
Therapeutic novelties in migraine: new drugs, new hope?
Thien Phu Do et al.
JOURNAL OF HEADACHE AND PAIN (2019)
Characterization of Dizziness After Lasmiditan Usage: Findings From the SAMURAI and SPARTAN Acute Migraine Treatment Randomized Trials
Stewart J. Tepper et al.
HEADACHE (2019)
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Ion channels
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein-coupled receptors
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Enzymes
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Investigation of distinct molecular pathways in migraine induction using calcitonin gene-related peptide and sildenafil
Samaira Younis et al.
CEPHALALGIA (2019)
Low-dose sodium valproate versus low-dose propranolol in prophylaxis of common migraine headache: A randomized, prospective, parallel, open-label study
Ganesh N. Dakhale et al.
INDIAN JOURNAL OF PHARMACOLOGY (2019)
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition
Jes Olesen
CEPHALALGIA (2018)
Flunarizine in migraine-related headache prevention: results from 200 patients treated in the UK
N. Karsan et al.
EUROPEAN JOURNAL OF NEUROLOGY (2018)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Erenumab on Exercise Time During a Treadmill Test in Patients With Stable Angina
Christophe Depre et al.
HEADACHE (2018)
Efficacy of fremanezumab in patients with chronic migraine with or without concomitant use of preventive medication
Peter J. Goadsby et al.
JOURNAL OF HEADACHE AND PAIN (2018)
CGRP as the target of new migraine therapies - successful translation from bench to clinic
Lars Edvinsson et al.
NATURE REVIEWS NEUROLOGY (2018)
Targeted Acid-Sensing Ion Channel Therapies for Migraine
Nazia Karsan et al.
NEUROTHERAPEUTICS (2018)
Orphan Drugs and Their Impact on Pharmaceutical Development
Misty M. Attwood et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2018)
Efficacy and safety of preservative-free timolol 0.1% gel in open-angle glaucoma and ocular hypertension in treatment-naive patients and patients intolerant to other hypotensive medications
S. Lazreg et al.
JOURNAL FRANCAIS D OPHTALMOLOGIE (2018)
Lasmiditan for the treatment of acute migraine: a review and potential role in clinical practice
Jessica C. Oswald et al.
JOURNAL OF PAIN RESEARCH (2018)
Botulinum toxins for the prevention of migraine in adults (Review)
Clare P. Herd et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2018)
Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25
Debbie L. Hay et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Treatment of disabling headache with greater occipital nerve injections in a large population of childhood and adolescent patients: a service evaluation
Francesca Puledda et al.
JOURNAL OF HEADACHE AND PAIN (2018)
Short-term effects of greater occipital nerve blocks in chronic migraine: A double-blind, randomised, placebo-controlled clinical trial
Maria L. Cuadrado et al.
CEPHALALGIA (2017)
High leptin levels are associated with migraine with aura
Claudia Pisanu et al.
CEPHALALGIA (2017)
The interaction between NGF-induced hyperalgesia and acid-provoked pain in the infrapatellar fat pad and tibialis anterior muscle of healthy volunteers
T. K. Munkholm et al.
EUROPEAN JOURNAL OF PAIN (2017)
Ketamine Infusions for Treatment Refractory Headache
Jared L. Pomeroy et al.
HEADACHE (2017)
The Trigeminovascular Pathway: Role of CGRP and CGRP Receptors in Migraine
Lars Edvinsson
HEADACHE (2017)
Selective Inhibition of Trigeminovascular Neurons by Fremanezumab: A Humanized Monoclonal Anti-CGRP Antibody
Agustin Melo-Carrillo et al.
JOURNAL OF NEUROSCIENCE (2017)
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Theo Vos et al.
LANCET (2017)
Fremanezumab for the Preventive Treatment of Chronic Migraine
Stephen D. Silberstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
A Controlled Trial of Erenumab for Episodic Migraine
Peter J. Goadsby et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
PATHOPHYSIOLOGY OF MIGRAINE: A DISORDER OF SENSORY PROCESSING
Peter J. Goadsby et al.
PHYSIOLOGICAL REVIEWS (2017)
Intranasal Lidocaine in Acute Treatment of Migraine: A Randomized Controlled Trial
Nazire Avcu et al.
ANNALS OF EMERGENCY MEDICINE (2017)
Migraine photophobia originating in cone-driven retinal pathways
Rodrigo Noseda et al.
BRAIN (2016)
A Randomized Trial of Ketorolac vs Sumatripan vs Placebo Nasal Spray (KSPN) for Acute Migraine
Aruna S. Rao et al.
HEADACHE (2016)
Altered effective connectivity of posterior thalamus in migraine with cutaneous allodynia: a resting-state fMRI study with granger causality analysis
Ting Wang et al.
JOURNAL OF HEADACHE AND PAIN (2016)
Characterising the premonitory stage of migraine in children: a clinic-based study of 100 patients in a specialist headache service
N. Karsan et al.
JOURNAL OF HEADACHE AND PAIN (2016)
Intravenous ketamine for subacute treatment of refractory chronic migraine: a case series
Clinton Lauritsen et al.
JOURNAL OF HEADACHE AND PAIN (2016)
Thalamo-cortical network activity during spontaneous migraine attacks
Gianluca Coppola et al.
NEUROLOGY (2016)
Wiping Out CGRP: Potential Cardiovascular Risks
Antoinette MaassenVanDenBrink et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2016)
Intravenous Subdissociative-Dose Ketamine Versus Morphine for Analgesia in the Emergency Department: A Randomized Controlled Trial
Sergey Motov et al.
ANNALS OF EMERGENCY MEDICINE (2015)
Calcitonin Gene-Related Peptide (CGRP): A New Target for Migraine
Andrew F. Russo
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 55 (2015)
Targeting CGRP: A New Era for Migraine Treatment
Stephanie Wrobel Goldberg et al.
CNS DRUGS (2015)
Photo-, osmo- and phonophobia in the premonitory phase of migraine: mistaking symptoms for triggers?
Laura H. Schulte et al.
JOURNAL OF HEADACHE AND PAIN (2015)
Migraine: Multiple Processes, Complex Pathophysiology
Rami Burstein et al.
JOURNAL OF NEUROSCIENCE (2015)
A Randomized Controlled Trial of Intranasal Ketamine in Major Depressive Disorder
Kyle A. B. Lapidus et al.
BIOLOGICAL PSYCHIATRY (2014)
Brain activations in the premonitory phase of nitroglycerin-triggered migraine attacks
Farooq Husain Maniyar et al.
BRAIN (2014)
BMS-927711 for the acute treatment of migraine: A double-blind, randomized, placebo controlled, dose-ranging trial
Ronald Marcus et al.
CEPHALALGIA (2014)
Selective inhibition of meningeal nociceptors by botulinum neurotoxin type A: Therapeutic implications for migraine and other pains
Rami Burstein et al.
CEPHALALGIA (2014)
Chaos and commotion in the wake of cortical spreading depression and spreading depolarizations
Daniela Pietrobon et al.
NATURE REVIEWS NEUROSCIENCE (2014)
Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention
Tony W. Ho et al.
NEUROLOGY (2014)
The effect of ketamine on optical and electrical characteristics of spreading depolarizations in gyrencephalic swine cortex
Renan Sanchez-Porras et al.
NEUROPHARMACOLOGY (2014)
Advances in kinase targeting: current clinical use and clinical trials
Mathias Rask-Andersen et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2014)
Emerging therapeutic options for acute migraine: focus on the potential of lasmiditan
Paul B. Rizzoli
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2014)
Serotonin, 5HT1 agonists, and migraine: new data, but old questions still not answered
Greg Dussor
CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE (2014)
Sumatriptan (all routes of administration) for acute migraine attacks in adults - overview of Cochrane reviews
Christopher J. Derry et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2014)
Pathophysiology of Migraine
Daniela Pietrobon et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 75 (2013)
Dihydroergotamine: A Review of Formulation Approaches For the Acute Treatment of Migraine
Stephen D. Silberstein et al.
CNS DRUGS (2013)
The Evolution of a Migraine Attack - A Review of Recent Evidence
Andrew Charles
HEADACHE (2013)
Glucose modulation of spreading depression susceptibility
Ulrike Hoffmann et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2013)
TRPA1 and other TRP channels in migraine
Silvia Benemei et al.
JOURNAL OF HEADACHE AND PAIN (2013)
Serotonin Facilitates Peripheral Pain Sensitivity in a Manner That Depends on the Nonproton Ligand Sensing Domain of ASIC3 Channel
Xiang Wang et al.
JOURNAL OF NEUROSCIENCE (2013)
Spreading Depression Triggers Headache by Activating Neuronal Panx1 Channels
Hulya Karatas et al.
SCIENCE (2013)
Antiepileptics other than gabapentin, pregabalin, topiramate, and valproate for the prophylaxis of episodic migraine in adults
Mattias Linde et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2013)
The cost of headache disorders in Europe: the Eurolight project
M. Linde et al.
EUROPEAN JOURNAL OF NEUROLOGY (2012)
TRPV1 receptor blockade is ineffective in different in vivo models of migraine
Oliver Summ et al.
CEPHALALGIA (2011)
Trigeminal Nociceptive Transmission in Migraineurs Predicts Migraine Attacks
Anne Stankewitz et al.
JOURNAL OF NEUROSCIENCE (2011)
Trends in the exploitation of novel drug targets
Mathias Rask-Andersen et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Combined occipital and supraorbital neurostimulation for the treatment of chronic migraine headaches: Initial experience
K. L. Reed et al.
CEPHALALGIA (2010)
OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial
S. K. Aurora et al.
CEPHALALGIA (2010)
OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial
H. C. Diener et al.
CEPHALALGIA (2010)
New drugs in migraine treatment and prophylaxis: telcagepant and topiramate
Lars Edvinsson et al.
LANCET (2010)
Topiramate Versus Amitriptyline in Migraine Prevention: A 26-Week, Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Noninferiority Trial in Adult Migraineurs
David W. Dodick et al.
CLINICAL THERAPEUTICS (2009)
EFNS guideline on the drug treatment of migraine - revised report of an EFNS task force
S. Evers et al.
EUROPEAN JOURNAL OF NEUROLOGY (2009)
Persistent increase in oxygen consumption and impaired neurovascular coupling after spreading depression in rat neocortex
Henning Piilgaard et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2009)
Antiepileptic drugs on calcium currents recorded from cortical and PAG neurons: therapeutic implications for migraine
G. Martella et al.
CEPHALALGIA (2008)
Effects of topiramate on migraine frequency and cortical excitability in patients with frequent migraine
A. R. Artemenko et al.
CEPHALALGIA (2008)
Oxcarbazepine in migraine headache - A double-blind, randomized, placebo-controlled study
S. Silberstein et al.
NEUROLOGY (2008)
Modulation of acid-sensing ion channel activity by nitric oxide
Herve Cadiou et al.
JOURNAL OF NEUROSCIENCE (2007)
Hypothalamic activation in spontaneous migraine attacks
Marie Denuelle et al.
HEADACHE (2007)
Cortical spreading depression causes and coincides with tissue hypoxia
Takahiro Takano et al.
NATURE NEUROSCIENCE (2007)
The triggers or precipitants of the acute migraine attack
L. Kelman
CEPHALALGIA (2007)
Topiramate inhibits trigeminovascular activation: an intravital microscopy study
S Akerman et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Aspirin is efficacious for the treatment of acute migraine
RB Lipton et al.
HEADACHE (2005)
Propranolol modulates trigeminovascular responses in thalamic ventroposteromedial nucleus: a role in migraine?
KG Shields et al.
BRAIN (2005)
pH dependency and desensitization kinetics of heterologously expressed combinations of acid-sensing ion channel subunits
M Hesselager et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Calcitonin gene-related peptide receptor antagonist BIBN4096BS for the acute treatment of migraine
J Olesen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat
RJ Storer et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Rofecoxib versus ibuprofen for acute treatment of migraine: a randomised placebo controlled trial
UK Misra et al.
POSTGRADUATE MEDICAL JOURNAL (2004)
Efficacy of candesartan in the treatment of migraine in hypertensive patients
K Owada
HYPERTENSION RESEARCH (2004)
Characterization of acid-sensing ion channels in dorsal horn neurons of rat spinal cord
LJ Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Candesartan reduces oxidative stress and inflammation in patients with essential hypertension
Y Dohi et al.
HYPERTENSION RESEARCH (2003)
Renin, angiotensin, sodium and organ damage
T Morgan
HYPERTENSION RESEARCH (2003)
Prophylactic treatment of migraine with an angiotensin II receptor blocker - A randomized controlled trial
E Tronvik et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Chronic pretreatment with candesartan improves recovery from focal cerebral ischaemia in rats
W Groth et al.
JOURNAL OF HYPERTENSION (2003)
Triptans (serotonin, 5-HT1B/1D agonists) in migraine:: detailed results and methods of a meta-analysis of 53 trials
MD Ferrari et al.
CEPHALALGIA (2002)
Stimulation of the greater occipital nerve induces increased central excitability of dural afferent input
T Bartsch et al.
BRAIN (2002)
Efficacy and tolerability in migraine prophylaxis of flunarizine in reduced doses: a comparison with propranolol 160 mg daily
HC Diener et al.
CEPHALALGIA (2002)
Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model
H Bolay et al.
NATURE MEDICINE (2002)
CGRP may play a causative role in migraine
LH Lassen et al.
CEPHALALGIA (2002)
Treatment patterns of isolated benign headache in US emergency departments
DR Vinson
ANNALS OF EMERGENCY MEDICINE (2002)
Colocalization of CGRP with 5-HT1B/1D receptors and substance P in trigeminal ganglion neurons in rats
QP Ma et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2001)
Angiotensin blockade inhibits increased JNKs, an-1 and NF-κB RNA-binding activities in myocardial infarcted rats
M Yoshiyama et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2001)
A new member of the acid-sensing ion channel family
AN Akopian et al.
NEUROREPORT (2000)
分享论文
